Safety of gender affirming treatment in assigned female at birth transgender people and association of androgen and estrogen β receptor polymorphisms with clinical outcomes

[1]  Yue Xu,et al.  Estrogen Mediates an Atherosclerotic-Protective Action via Estrogen Receptor Alpha/SREBP-1 Signaling , 2022, Frontiers in Cardiovascular Medicine.

[2]  S. Kliesch,et al.  The HEAT-Registry (HEmatopoietic Affection by Testosterone): comparison of a transdermal gel vs long-acting intramuscular testosterone undecanoate in hypogonadal men , 2022, The aging male : the official journal of the International Society for the Study of the Aging Male.

[3]  I. Lambrinoudaki,et al.  Menopause-associated risk of cardiovascular disease , 2022, Endocrine connections.

[4]  A. Lenzi,et al.  Epigenetic Effects of Gender-Affirming Hormone Treatment: A Pilot Study of the ESR2 Promoter’s Methylation in AFAB People , 2022, Biomedicines.

[5]  G. Motta,et al.  SIGIS–SIAMS–SIE position statement of gender affirming hormonal treatment in transgender and non-binary people , 2021, Journal of Endocrinological Investigation.

[6]  Fertility evaluation of infertile women: a committee opinion. , 2021, Fertility and sterility.

[7]  D. Roblin,et al.  Longitudinal Changes in Liver Enzyme Levels Among Transgender People Receiving Gender Affirming Hormone Therapy , 2021, The journal of sexual medicine.

[8]  T. Capursi,et al.  Hormone therapy in female-to-male transgender patients: searching for a lifelong balance , 2020, Hormones.

[9]  F. Keleştimur,et al.  The role of androgen receptor CAG repeat polymorphism in androgen excess disorder and idiopathic hirsutism , 2020, Journal of Endocrinological Investigation.

[10]  AIUM Practice Parameter for the Performance of an Ultrasound Examination of the Female Pelvis , 2020, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[11]  A. Lenzi,et al.  Polymorphic Cytosine-Adenine-Guanine Repeat Length of Androgen Receptor Gene and Gender Incongruence in Trans Women: A Systematic Review and Meta-Analysis of Case-Control Studies. , 2020, The journal of sexual medicine.

[12]  Kate Godfrey,et al.  Balance , 2019, Theatre, Dance and Performance Training.

[13]  P. Kantoff,et al.  Mechanisms responsible for reduced erythropoiesis during androgen deprivation therapy in men with prostate cancer. , 2018, American journal of physiology. Endocrinology and metabolism.

[14]  J. Arcelus,et al.  Endocrinology of Transgender Medicine. , 2018, Endocrine reviews.

[15]  S. Bhasin,et al.  The Efficacy and Adverse Events of Testosterone Replacement Therapy in Hypogonadal Men: A Systematic Review and Meta-Analysis of Randomized, Placebo-Controlled Trials , 2018, The Journal of clinical endocrinology and metabolism.

[16]  O. Kalter‐Leibovici,et al.  The effect of CAG repeats length on differences in hirsutism among healthy Israeli women of different ethnicities , 2018, PloS one.

[17]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[18]  L. Prokop,et al.  Sex Steroids and Cardiovascular Outcomes in Transgender Individuals: A Systematic Review and Meta‐Analysis , 2017, The Journal of clinical endocrinology and metabolism.

[19]  P. Cohen-Kettenis,et al.  Endocrine Treatment of Gender‐Dysphoric/Gender‐Incongruent Persons: An Endocrine Society* Clinical Practice Guideline , 2017, The Journal of clinical endocrinology and metabolism.

[20]  D. Gibson,et al.  Androgens and endometrium: New insights and new targets , 2017, Molecular and Cellular Endocrinology.

[21]  R. Andreotti,et al.  The Normal Female Pelvis. , 2017, Clinical obstetrics and gynecology.

[22]  L. Resta,et al.  Uterine and ovarian changes during testosterone administration in young female-to-male transsexuals. , 2016, Taiwanese journal of obstetrics & gynecology.

[23]  Lisa R Tannock,et al.  METABOLIC EFFECTS OF HORMONE THERAPY IN TRANSGENDER PATIENTS. , 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[24]  G. Motta,et al.  Quality of life and hormones after sex reassignment surgery , 2015, Journal of Endocrinological Investigation.

[25]  A. Lenzi,et al.  Influence of CAG Repeat Polymorphism on the Targets of Testosterone Action , 2015, International journal of endocrinology.

[26]  J. Kaufman,et al.  Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence. , 2014, The journal of sexual medicine.

[27]  A. Guillamón,et al.  The (CA)n polymorphism of ERβ gene is associated with FtM transsexualism. , 2014, The journal of sexual medicine.

[28]  Y. Kakeji,et al.  Estrogen receptor‐β gene polymorphism and colorectal cancer risk: Effect modified by body mass index and isoflavone intake , 2013, International journal of cancer.

[29]  M. Muramatsu,et al.  Association between estrogen receptor-β dinucleotide repeat polymorphism and incidence of femoral fracture , 2013, Journal of Bone and Mineral Metabolism.

[30]  M. Alevizaki,et al.  Severity of coronary artery disease in postmenopausal women: association with the androgen receptor gene (CAG)n repeat polymorphism , 2011, Menopause.

[31]  J. Lowrey,et al.  In Silico Analysis Identifies a Novel Role for Androgens in the Regulation of Human Endometrial Apoptosis , 2011, The Journal of clinical endocrinology and metabolism.

[32]  Tai C. Chen,et al.  Alterations in Lipids and Adipocyte Hormones in Female-to-Male Transsexuals , 2010, International journal of endocrinology.

[33]  N. Hara,et al.  Decline of the red blood cell count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor-1 and erythropoiesis. , 2010, Urology.

[34]  P. Fuller,et al.  The importance of ERbeta signalling in the ovary. , 2010, The Journal of endocrinology.

[35]  P. Saunders,et al.  Attenuated sex steroid receptor expression in fallopian tube of women with ectopic pregnancy. , 2009, The Journal of clinical endocrinology and metabolism.

[36]  P. Lara,et al.  The GGN and CAG repeat polymorphisms in the exon-1 of the androgen receptor gene are, respectively, associated with insulin resistance in men and with dyslipidemia in women , 2009, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  G. Ning,et al.  Androgen receptor gene CAGn trinucleotide repeats polymorphism in Chinese women with polycystic ovary syndrome , 2008, Endocrine.

[38]  K. Ueno,et al.  Functional analysis of transcriptional activity of cytosine and adenine (CA) repeats polymorphism in the estrogen receptor beta gene. , 2008, The Journal of toxicological sciences.

[39]  J. Manson,et al.  Genetic Variation of the Androgen Receptor and Risk of Myocardial Infarction and Ischemic Stroke in Women , 2008, Stroke.

[40]  M. Zitzmann.  Mechanisms of Disease: pharmacogenetics of testosterone therapy in hypogonadal men , 2007, Nature Clinical Practice Urology.

[41]  M. Hersberger,et al.  The CAG repeat polymorphism in the androgen receptor gene is associated with HDL-cholesterol but not with coronary atherosclerosis or myocardial infarction. , 2005, Clinical chemistry.

[42]  E. Nieschlag,et al.  X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  J. Lekakis,et al.  The androgen receptor gene CAG polymorphism is associated with the severity of coronary artery disease in men , 2003, Clinical endocrinology.

[44]  P. Björntorp,et al.  Polymorphisms of the Androgen Receptor Gene and the Estrogen Receptor β Gene Are Associated with Androgen Levels in Women1 , 2001 .

[45]  Richard A. Anderson,et al.  Differential Expression of Estrogen Receptor-α and -β and Androgen Receptor in the Ovaries of Marmosets and Humans , 2000 .

[46]  J. L. San Millán,et al.  The role of the CAG repeat polymorphism in the androgen receptor gene and of skewed X-chromosome inactivation, in the pathogenesis of hirsutism. , 2000, The Journal of clinical endocrinology and metabolism.

[47]  A. Shalita,et al.  Androgen Receptor Polymorphisms (CAG Repeat Lengths) in Androgenetic Alopecia, Hirsutism, and Acne , 1998, Journal of cutaneous medicine and surgery.

[48]  T. H. van der Kwast,et al.  Androgen receptor expression in human ovarian and uterine tissue of long-term androgen-treated transsexual women. , 1994, Human pathology.

[49]  P. Dandona,et al.  Serum gonadotrophin concentrations in men with peripheral vascular disease and impotence. , 1989, BMJ.

[50]  J. Kaufman,et al.  Short- and long-term clinical skin effects of testosterone treatment in trans men. , 2014, The journal of sexual medicine.

[51]  F. Greenway,et al.  An Endocrine Society Clinical Practice Guideline Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: , 2010 .

[52]  A. von Eckardstein,et al.  The CAG repeat polymorphism in the androgen receptor gene modulates body fat mass and serum concentrations of leptin and insulin in men , 2002, Diabetologia.

[53]  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society Effects of Sex Steroid Deprivation/Administration on Hair Growth and Skin Sebum Production in Transsexual Males and Females , 2000 .

[54]  B. Orr,et al.  Differential expression of estrogen receptor-alpha and -beta and androgen receptor in the ovaries of marmosets and humans. , 2000, Biology of reproduction.

[55]  G. Morgante,et al.  Hormonal effects of flutamide in young women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[56]  N. Golden,et al.  in Women with , 1992 .

[57]  W. Futterweit,et al.  Histopathological effects of exogenously administered testosterone in 19 female to male transsexuals , 1986 .